Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma

Pediatric Blood and Cancer

Volumn 46, Issue 7, 2006, Pages 786-792

  Schroeder, Henrik ^a   Kamperis, Konstatinos ^a   Grunnet, Niels ^a   Hokland, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CD34+ cells; Leukopheresis; Mobilization; Neuroblastoma

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MYELOABLATIVE AGENT; NB 87; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BODY WEIGHT; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; LEUKAPHERESIS; LYMPHOCYTE COUNT; MALE; MYELOABLATIVE CONDITIONING; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STEM CELL MOBILIZATION; SURVIVAL TIME;

ANTIGENS, CD34; CELL COUNT; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; LEUKAPHERESIS; LINEAR MODELS; MALE; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 33646588650     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20651     Document Type: Article

References (39)

1. Matthay KK, Villabianca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-1173.
2. Meldgaard KL, Jensen L. Gaarsdal E, et al. A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophosphamide plus rhG-CSF. Bone Marrow Transplant 2000;26:717-722.
3. de Fabritiis P, Gonzalez M, Meloni G, et al. Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells. Bone Marrow Transplant 1999;23:1229-1236.
4. Diaz MA, Garcia-Sanchez F, Lillo R, et al. Large-volume leukapheresis in pediatric patients: Pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield, off. Haematologica 1999;84:32-35.
5. Kanold J, Halle P, Berger M, et al. Large-volume leukapheresis procedure for peripheral blood progenitor cell collection in children weighing 15 kg or less: Efficacy and safety evaluation. Med Pediatrbncol 1999;32:7-10.
6. Diaz MA, Alegre A, Benito A, et al. Peripheral blood progenitor cell collection by large-volume leukapheresis in low-weight children. J Hematother 1998;7:63-68.
7. Kanold J, Berger M, Halle P, et al. Kinetics of hematopoietic progenitor cell release induced by G-CSF-alone in children with solid tumors and leukemias. Bone Marrow Transplant 1998;21:59-63.
8. Engel BC, Laws HJ, Dirksen U, et al. Circulating CD344+ cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing tumor patients. Klin Padiatr 1997;209:186-190.
9. Nussbaumer W, Schonitzer D, Trieb T, et al. Peripheral blood stem cell (PBSC) collection in extremely low-weight infants. Bone Marrow Transplant 1996;18:15-17.
10. Alegre A, Diaz MA, Madero L, et al. Large-volume leukapheresis for peripheral blood stem cell collection in children: A simplified single-apheresis approach. Bone Marrow Transplant 1996;17:923-927.
11. Ladenstein R, On behalf of ESIOP. High Risk Neuroblastoma. Study 1 of SIOP Europe (HR-NBL-1/ESIOP) Version 2001. 1-6-2001. Ref Type: Generic.
12. Ladenstein R. Personal communication. 2004. Ref Type: Generic.
13. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995;13:2547-2555.
14. Bashey A, Corringham S, Gilpin E, et al. Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation. Cytotherapy 2000;2:195-200.
15. Narayanasami U, Kanteti R, Morelli J, et al. Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood 2001;98:2059-2064.
16. Sevilla J, Gonzalez-Vicent M, Madero L, et al. Granulocytecolony- stimulating factor alone at 12 microg/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients. Bone Marrow Transplant 2002;30:417-420.
17. Green RH, Watson D, Buchanan S, et al. A prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (auto PBSC) and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non-haematological malignancies. Transfus Apheresis Sci 2001;24:85-90.
18. Mehta J, Singhal S, Gordon L, et al. Cobe Spectra is superior to Fenwal CS 3000 Plus for collection of hematopoietic stem cells. Bone Marrow Transplant 2002;29:563-567.
19. Dobo I, Robillard N, Pineau D, et al. Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: A bicentric analysis of 299 leukaphereses. Ann Hematol 2001;80:639-646.
20. Fontao-Wendel R, Lazar A, Melges S, et al. The absolute number of circulating CD34+ cells as the best predictor of peripheral hematopoietic stem cell yield. J Hematother 1999;8:255-262.
21. Knudsen LM, Gaarsdal E, Jensen L, et al. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells. J Hematother 1996;5:399-406.
22. Knudsen LM, Gaarsdal E, Jensen L, et al. Evaluation of mobilized CD34+ cell counts to guide timing and yield of large-scale collection by leukapheresis. J Hematother 1998;7:45-52.
23. Leibundgut K, von Rohr A, Brulhart K, et al. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children. Bone Marrow Transplant 1995;15:25-31.
24. Kushner BH, Laquaglia MP, Bonilla MA, et al. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 1994;12:2607-2613.
25. Philip T, Zucker JM, Bernard JL, et al. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup? J Clin Oncol 1991;9:1037-1044.
26. Pritchard J, Cotterill SJ, Germond SM, et al. High dose melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer 2005;44:348-357.
27. Sutherland DR, Anderson L, Keeney M, et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. Internalional Society of Hematotherapy and Graft Engineering. J Hematother 1996;5:213-226.
28. Halle P, Kanold J, Rapatel C, et al. Granulocyte colony-stimulating factor alone at 20 micrograms/kg versus 10 micrograms/kg for peripheral blood stem cell mobilization in children. Pediatr Transplant 2000;4:285-288.
29. Kurekci AE, Kiss JE, Koehler M. Mobilization of peripheral blood progenitor cells using 16 versus 10 mg/kg/d G-CSF in children with malignancies. Pediatr Transplant 1998;2:160-164.
30. Demirer T, Ayli M, Ozcan M, et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): A randomized evaluation of different doses of rhG-CSF. Br J Haematol 2002;116:468-474.
31. Kroger N, Renges H, Kruger W, et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 2000;111:761-765.
32. Cassens U, Momkvist PH, Zuehlsdorf M, et al. Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC). Bone Marrow Transplant 2001;28:13-20.
33. Gorlin JB, Humphreys D, Kent P, et al. Pediatric large volume peripheral blood progenitor cell collections from patients under 25 kg: A primer. J Clin Apheresis 1996;11:195-203.
34. Yamaguchi E, Yamato K, Miyata Y. Kinetics of peripheral blood stem cell collection in large-volume leukapheresis for pediatric patients undergoing chemotherapy and adult patients before chemotherapy. J Hematother Stem Cell Res 2000;9:565-572.
35. Cassens U, Ostkamp-Ostermann P, van der WN, et al. Volume-dependent collection of peripheral blood progenitor cells during large-volume leukapheresis for patients with solid tumours and haematological malignancies. Transfus Med 1999;9:311-320.
36. Ford CD, Greenwood J, Strupp A, el al. Change in CD34+ cell concentration during peripheral blood progenitor cell collection: Effects on collection efficiency and efficacy. Transfusion 2002;42:904-911.
37. Knudsen LM, Nikolaisen K, Gaarsdal E, el al. Kinetic studies during peripheral blood stem cell collection show CD34+ cell recruitment intra-apheresis. J Clin Apheresis 2001;16:114-119.
38. Humpe A, Riggert J, Koch S, et al. Prospective, randomized, sequential, crossover trial of large-volume vs. normal-volume leukapheresis procedures: Effects on subpopulations of CD34(+) cells. J Clin Apheresis 2001;16:109-113.
39. Demirer T, Dagli M, Ilhan O, et al. A randomized trial of assessment of efficacy of leukapheresis volumes. 8 liters versus 12 liters. Bone Marrow Transplant 2002;29:893-897.